Stay updated on Olaparib Plus Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the Olaparib Plus Pembrolizumab Clinical Trial page.

Latest updates to the Olaparib Plus Pembrolizumab Clinical Trial page
- CheckyesterdayChange DetectedFooter now displays Revision: v3.3.4; the previous Revision: v3.3.3 entry was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedAdded Revision: v3.3.3; removed HHS Vulnerability Disclosure and Revision: v3.3.2.SummaryDifference0.1%

- Check51 days agoChange DetectedRevision: v3.3.2 was added to the page. Revision: v3.2.0 was removed.SummaryDifference0.0%

- Check58 days agoChange DetectedRemoved a general site-wide notice about government funding and the NIH Clinical Center's operating status; this deletion does not affect trial information or data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check72 days agoChange DetectedThe Record History now includes a new version entry (Version 147, submitted 2025-03-14) to the study's history.SummaryDifference0.0%

- Check101 days agoChange DetectedMajor update: announces a version upgrade to v3.2.0 and publicly states funding-related operational notices, including that transactions may not be processed until appropriations are enacted.SummaryDifference6%

Stay in the know with updates to Olaparib Plus Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Olaparib Plus Pembrolizumab Clinical Trial page.